In the present study, postmenopausal HR-positive/HER2-negative breast cancer patients with good serum lipid control due to the agents for dyslipidaemia showed significantly longer RFS, and these patients also had significantly lower postoperative NLR. Here, ERBB2 is linked to breast cancer.